<DOC>
	<DOCNO>NCT00655109</DOCNO>
	<brief_summary>To compare clinical efficacy olopatadine fluticasone 3-week single center , double-masked , randomize , placebo control parallel treatment conjunctival allergen challenge ( CAC ) study patient allergic conjunctivitis</brief_summary>
	<brief_title>A Comparison Olopatadine Fluticasone Patients With Allergic Conjunctivitis</brief_title>
	<detailed_description>Study evaluate efficacy nasal anti-allergic therapy compare ocular anti-allergic therapy prevention ocular allergic symptom .</detailed_description>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Lubricant Eye Drops</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Olopatadine Hydrochloride</mesh_term>
	<criteria>At least 18 year age &amp; either sex , race Willing able follow instruction attend study visit Positive history ocular allergy Reproducible positive ocular allergic reaction induce conjunctival allergen challenge Have plan surgery trial period Female currently pregnant , plan pregnancy , lactate Use disallow medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Allergic conjunctivitis</keyword>
	<keyword>Allergic rhinoconjunctivitis</keyword>
</DOC>